Mucositis News and Research

RSS
Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Use of feeding tubes in OPC cancer patients treated with IMPT decreased by 50%

Use of feeding tubes in OPC cancer patients treated with IMPT decreased by 50%

Soligenix awarded $6.4M contract to advance preclinical development of OrbeShield for GI ARS

Soligenix awarded $6.4M contract to advance preclinical development of OrbeShield for GI ARS

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

European Commission approves Stivarga tablets for treatment of patients with mCRC

European Commission approves Stivarga tablets for treatment of patients with mCRC

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Soligenix announces personalized medicine collaboration with SciClone

Soligenix announces personalized medicine collaboration with SciClone

First clinical study for development of SGX203 to treat pediatric Crohn's disease

First clinical study for development of SGX203 to treat pediatric Crohn's disease

Soligenix receives FDA Fast Track designation for SGX942 to treat patients with oral mucositis

Soligenix receives FDA Fast Track designation for SGX942 to treat patients with oral mucositis

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Soligenix starts first clinical study for development of SGX203 for pediatric Crohn's disease

Soligenix starts first clinical study for development of SGX203 for pediatric Crohn's disease

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Study: Image-guided brachytherapy prevents growth of cervical tumour in over 90% of patients

Study: Image-guided brachytherapy prevents growth of cervical tumour in over 90% of patients

BIND Therapeutics presents positive Phase 1 clinical study results for BIND-014 at AACR meeting

BIND Therapeutics presents positive Phase 1 clinical study results for BIND-014 at AACR meeting

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis